Elanco Animal Health (ELAN) Cash from Investing Activities Growth (3y) (2020 - 2026)
Elanco Animal Health (ELAN) Cash from Investing Activities Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | -53.63% |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | -55.36% |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | 34.35% |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | 33.61% |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | 15.92% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -2.45% |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | -36.76% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.47 Bn | 397.90 Mn | -26.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -36.76% |
| Mar 31, 2026 | -2.94% |
| Dec 31, 2025 | 5.57% |
| Sep 30, 2025 | -39.76% |
| Jun 30, 2025 | -14.81% |
| Mar 31, 2025 | -25.99% |
| Dec 31, 2024 | -6.74% |
| Sep 30, 2024 | 68.93% |
| Jun 30, 2024 | -9.70% |
| Mar 31, 2024 | 54.67% |
| Dec 31, 2023 | 22.09% |
| Sep 30, 2023 | 80.28% |
| Jun 30, 2023 | -80.79% |
| Mar 31, 2023 | -40.10% |
| Dec 31, 2022 | -0.67% |
| Sep 30, 2022 | 23.61% |
| Jun 30, 2022 | 7.33% |
| Mar 31, 2022 | 2.20% |
| Dec 31, 2021 | -15.44% |
| Sep 30, 2021 | -174.16% |